drugset
drugset / Trial / NCT05090657

Nasal Photodisinfection in All Patients Presenting for Surgery for a Wide Range of Surgical Procedures

NCT05090657 ↗

Phase 2 Completed 322 enrolled Ondine Biomedical Inc.
NaSingle-groupOpen-labelPrevention

Summary

This is a Phase 2 single-center, open-label, single-arm, study of a microbiological endpoint using antimicrobial photodynamic therapy (aPDT) for nasal disinfection in all patients (universal) presenting for surgery at an acute care hospital for a wide range of surgical procedures.

Timeline

Start
2022-02-04
Primary completion
2022-08-06
Completion
2022-08-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Chlorhexidine gluconate Other / unclassified 0.25 % Topical
Subject Methylene Blue Diagnostic / imaging agent 0.01 % Topical

Indications

nosocomial infection